Cancer Cell Biology Overview

Principles

Definition

Cancer cell biology is an academic and research field dedicated to the investigation of the fundamental cellular and molecular mechanisms that drive the initiation, progression, and metastasis of cancer. It examines the genetic, epigenetic, and environmental factors that lead to uncontrolled cell proliferation, altered differentiation, resistance to apoptosis, and the complex interactions within the tumor microenvironment, aiming to elucidate the biological basis of malignancy and identify potential therapeutic strategies.

Ontological type

Hallmark Processes

Genetic Drivers

Tumor Microenvironment

Key developments

Key Figures

Cellular Models & Transformation era

George J. Todaro [1], associated with University of Massachusetts Chan Medical School [3] and University of Washington [4], was a central figure in the Cellular Models & Transformation era. His key contributions include the paper In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2 [7], establishing in vitro cultivation of human tumors and the creation of solid-tumor cell lines, and the paper Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors [8], which revealed growth factor signaling relevant to transformation. Stuart A. Aaronson [2], associated with Harvard University [5] and University of California, San Francisco [6], was a cornerstone of the era's cell-based cancer research. His key contribution in this era centers on the In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2 [7], a foundational study that established reproducible tumor cell lines enabling quantitative studies of growth dynamics and transformation.

Signaling–Genome Integrity Nexus era

Steven A. Narod [1] was active during this era with affiliations at the Institute of Cancer Research [3] and the University of Pennsylvania [4]. A key contribution was the identification of BRCA1 [7] as a strong candidate gene for breast and ovarian cancer susceptibility, linking hereditary risk to DNA damage response and genome maintenance in a way that clarified how signaling networks interact with genome integrity in this era. Susan L. Neuhausen [2] is listed with Yale University [5] and the University of Cambridge [6]. Her contribution via BRCA1 [7] helped define BRCA1 as a pivotal gene for hereditary breast and ovarian cancer, advancing understanding of genetic susceptibility and genome stability within signaling–genome integrity networks.

Epigenetic & RNA Plasticity era

Peter J. Campbell [1] is a cancer researcher associated with Baylor College of Medicine [3] and Albert Einstein College of Medicine [4] during the Epigenetic & RNA Plasticity era. His key contribution in this era includes advancing COSMIC: the Catalogue Of Somatic Mutations In Cancer [7], a comprehensive mutation resource that enabled cross-study integration of genetic and epigenetic data. Marc J. van de Vijver [2] is linked with the College of American Pathologists [5] and Rockefeller University [6] during this era. His work on Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis [8] and Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival [9] advanced prognostic assays and illuminated how transcriptional signatures inform tumor heterogeneity and therapeutic strategies.